Back
Legend Biotech Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
30
LEGN
Legend Biotech
Last Price:
51.49
Seasonality Move:
9.49%
Sell
25
ALNY
Alnylam Pharmaceuticals
Last Price:
270.24
Seasonality Move:
5.61%
Sell
30
Legend Biotech (LEGN)
is a Sell
Is Legend Biotech a Buy, Sell or Hold?
- The current Legend Biotech [LEGN] share price is $50.31. The Score for LEGN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- LEGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $265.27. The Score for ALNY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LEGN Stock Price Chart
What is Legend Biotech's stock price today?
-
The Legend Biotech share price today is $50.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEGN is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $265.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
LEGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.35 | Sell |
Relative Strength Index (14 RSI): | 37.7 | Sell |
Chaikin Money Flow: | -271494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.98 - 57.98) | Sell |
Bollinger Bands (100): | (43.22 - 55.54) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 53.6 | Buy |
Chaikin Money Flow: | 403934 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (256.2 - 277.22) | Sell |
Bollinger Bands (100): | (158.9 - 265.08) | Buy |
LEGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.33 | Sell |
20-day SMA: | 54.74 | Sell |
50-day SMA: | 54.82 | Sell |
200-day SMA: | 54.28 | Sell |
8-day EMA: | 51.48 | Sell |
20-day EMA: | 53.45 | Sell |
50-day EMA: | 53.37 | Sell |
200-day EMA: | 54.23 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 256.17 | Buy |
20-day SMA: | 266.77 | Sell |
50-day SMA: | 258.27 | Buy |
200-day SMA: | 189.51 | Buy |
8-day EMA: | 260.57 | Buy |
20-day EMA: | 261.96 | Buy |
50-day EMA: | 250.03 | Buy |
200-day EMA: | 205.35 | Buy |
Legend Biotech Earnings Growth & LEGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.19 per share, an increase this year of $1.77 per share, and an increase next year of $0.54 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Legend Biotech Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |